Agreeing to Submission Document Timelines & Sticking to Them: Fairy Tale or Reality?
In this webinar, Steve Sibley defined best practices for establishing submission timelines that won’t change,…
CertaraSeptember 14, 2017
Drug Asset Evaluation: Increasing “Probability of Success” of a Deal
Certara’s due diligence/asset evaluation teams are comprised of drug development and commercialization experts who advise…
CertaraAugust 24, 2017
Investigational Drug Gap Analysis
As the process of drug development has increased in cost and complexity, Certara has developed…
CertaraAugust 14, 2017
Clinical Pharmacology—The Quarterback of Drug Development
Clinical pharmacology accounts for about 50% of a drug label. Its scope ranges from facilitating…
CertaraAugust 14, 2017
